Face-to-Face and Digital Multidomain Lifestyle Interventions to Enhance Cognitive Reserve and Reduce Risk of Alzheimer’s Disease and Related Dementias: A Review of Completed and Prospective Studies
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Background: Currently, there is no pharmaceutical intervention to treat or delay pathological cognitive decline or Alzheimer’s disease and related dementias (ADRD). Multidomain lifestyle interventions are increasingly being studied as a non-pharmacological solution to enhance cognitive reserve, maintain cognition, and reduce the risk of or delay ADRD. Review of completed and prospective face-to-face (FTF) and digital multidomain interventions provides an opportunity to compare studies and informs future interventions and study design. Methods: Electronic databases (PubMed, PsycINFO, clinicaltrials.gov and NIH RePORTER) were searched for multidomain lifestyle programs. Studies were included if the program (1) included a control group, (2) included at least 3 interventions, (3) were at least 6 months in duration, and (4) included measurement of cognitive performance as an outcome. Results: In total, 17 multidomain lifestyle programs aimed at enhancing cognitive reserve and reducing risk of ADRD were found. Thirteen programs are FTF in intervention delivery, with 3 FTF programs replicating the FINGER protocol as part of the World Wide Fingers Consortium. Four programs are delivered digitally (website, Web application, or mobile app). Program characteristics (e.g., target population, duration, frequency, outcomes, and availability) and results of completed and prospective studies are reviewed and discussed. Conclusion: This review updates and discusses completed and current multidomain lifestyle interventions aimed at enhancing cognitive reserve and reducing risk of ADRD. A growing number of international studies are investigating the efficacy and utility of these programs in both FTF and digital contexts. While a diversity of study designs and interventions exist, FTF and digital programs that build upon the foundational work of the FINGER protocol have significant potential to enhance cognitive reserve and reduce risk of ADRD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325
Dementia prevention, intervention, and care
Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31363-6 · Cited by 6,072
Ngandu, T., Lehtisalo, J., Solomon, A., Levälahti, E., Ahtiluoto, S., Antikainen, R., Bäckman, L., Hänninen, T., Jula, A., Laatikainen, T., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60461-5 · Cited by 3,689 · cited 2×
“A “top-down” approach to lifestyle interventions, beginning with cognitive health, has demonstrated improvements in cognition [36], health-related quality of life [37], self-perceived physical function and general health [39], and chronic disease risk reduction [38].”
BackgroundResultEffects of Cognitive Training Interventions With Older Adults: A Randomized Controlled Trial
Ball, K., Berch, D. B., Helmers, K. F., Jobe, J. B., Leveck, M. D., Marsiske, M., Morris, J. N., Rebok, G. W., Smith, D. M., Tennstedt, S. L., et al. (2002) · JAMA · doi:10.1001/jama.288.18.2271 · Cited by 2,049
2018 Alzheimer's disease facts and figures
Alzheimer's Association (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.001 · Cited by 1,912
Alzheimer’s disease drug-development pipeline: Few candidates, frequent failures
Cummings, J. L., Morstorf, T., & Zhong, K. (2014) · Alzheimer's Research & Therapy · doi:10.1186/alzrt269 · Cited by 1,744 · cited 2×
“To date, trials targeting individuals with detectable cognitive or cognitive and functional impairment have failed [65].”
BackgroundLong-term Effects of Cognitive Training on Everyday Functional Outcomes in Older Adults
Willis, S. L., Tennstedt, S. L., Marsiske, M., Ball, K., Elias, J., Koepke, K. M., Morris, J. N., Rebok, G. W., Unverzagt, F. W., Stoddard, A. M., et al. (2006) · JAMA · doi:10.1001/jama.296.23.2805 · Cited by 1,496
Williamson (2019) · doi:10.1001/jama.2018.21442 · Cited by 1,246 · cited 1×
“The SPRINT-MIND study was a sub-study of the SPRINT study to examine how intensive blood pressure interventions affect the incidence of MCI and dementia [42].”
MethodLifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease
Kivipelto, M., Mangialasche, F., & Ngandu, T. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0070-3 · Cited by 1,173
Rebok, G. W., Ball, K., Guey, L. T., Jones, R. N., Kim, H., King, J. W., Marsiske, M., Morris, J. N., Tennstedt, S. L., Unverzagt, F. W., et al. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12607 · Cited by 965
Blondell, S. J., Hammersley-Mather, R., & Veerman, J. L. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-510 · Cited by 928
Association of Lifestyle and Genetic Risk With Incidence of Dementia
Lourida, I., Hannon, E., Littlejohns, T. J., Langa, K. M., Hyppönen, E., Kuzma, E., & Llewellyn, D. J. (2019) · JAMA · doi:10.1001/jama.2019.9879 · Cited by 881
A meta-analysis of computer-tailored interventions for health behavior change
Krebs, P., Prochaska, J. O., & Rossi, J. S. (2010) · Preventive Medicine · doi:10.1016/j.ypmed.2010.06.004 · Cited by 854 · cited 1×
“Adherence to digitally delivered programs is an important area of current research [91,92], with evidence supporting the role of content and intervention tailoring to specific populations and individuals to improve adherence [93,94].”
BackgroundResistance Training and Executive Functions: A 12-Month Randomized Controlled Trial
Liu-Ambrose, T. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.494 · Cited by 775
A meta-analysis of web-delivered tailored health behavior change interventions
Lustria, M. L. A., Noar, S. M., Cortese, J., Van Stee, S. K., Glueckauf, R. L., & Lee, J. (2013) · Journal of Health Communication · doi:10.1080/10810730.2013.768727 · Cited by 689 · cited 1×
“Adherence to digitally delivered programs is an important area of current research [91,92], with evidence supporting the role of content and intervention tailoring to specific populations and individuals to improve adherence [93,94].”
Backgroundvan Charante, E. P. M., Richard, E., Eurelings, L. S., van Dalen, J.-W., Ligthart, S. A., van Bussel, E. F., Hoevenaar-Blom, M. P., Vermeulen, M., & van Gool, W. A. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30950-3 · Cited by 611
Kivipelto, M., Solomon, A., Ahtiluoto, S., Ngandu, T., Lehtisalo, J., Antikainen, R., Bäckman, L., Hänninen, T., Jula, A., Laatikainen, T., et al. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.09.012 · Cited by 589 · cited 5×
“The Finish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) The FINGER study was one of the earlier multidomain intervention studies carried out to investigate the prevention of cognitive decline and related disability in a population of at-risk older adult participants from across…”
MethodInfluentialDrug treatments in Alzheimer’s disease
Briggs, R., Kennelly, S. P., & O’Neill, D. (2016) · Clinical Medicine · doi:10.7861/clinmedicine.16-3-247 · Cited by 571 · cited 1×
“One of the enduring challenges in the development of pharmacological DMTs for ADRD has been intervening at the point in disease progression that is clinically efficacious [78].”
BackgroundPerson-specific contribution of neuropathologies to cognitive loss in old age
Boyle, P. A., Yu, L., Wilson, R. S., Leurgans, S. E., Schneider, J. A., & Bennett, D. A. (2018) · Annals of Neurology · doi:10.1002/ana.25123 · Cited by 508 · cited 1×
“, vascular pathology) [84] with interactions between pathologies posited in the initiation and accumulation of pathological burden [85].”
BackgroundDrug development in Alzheimer’s disease: the path to 2025
Cummings, J., Aisen, P. S., DuBois, B., Frölich, L., Jack, C. R., Jones, R. W., Morris, J. C., Raskin, J., Dowsett, S. A., & Scheltens, P. (2016) · Alzheimer's Research & Therapy · doi:10.1186/s13195-016-0207-9 · Cited by 459
Rosenberg, A., Ngandu, T., Rusanen, M., Antikainen, R., Bäckman, L., Havulinna, S., Hänninen, T., Laatikainen, T., Lehtisalo, J., Levälahti, E., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.09.006 · Cited by 421
Vascular risk factors and dementia: How to move forward?
Viswanathan, A., Rocca, W. A., & Tzourio, C. (2009) · Neurology · doi:10.1212/01.wnl.0000341271.90478.8e · Cited by 414
Sink, K. M., Espeland, M. A., Castro, C. M., Church, T., Cohen, R., Dodson, J. A., Guralnik, J., Hendrie, H. C., Jennings, J., Katula, J., et al. (2015) · JAMA · doi:10.1001/jama.2015.9617 · Cited by 402
Zhong, G., Wang, Y., Zhang, Y., Guo, J. J., & Zhao, Y. (2015) · PLOS ONE · doi:10.1371/journal.pone.0118333 · Cited by 362
Lara, E., Martín-María, N., De la Torre-Luque, A., Koyanagi, A., Vancampfort, D., Izquierdo, A., & Miret, M. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.03.002 · Cited by 351 · cited 13×
“The Systolic Blood Pressure Intervention Trial (SPRINT; SPRINT-MIND) The SPRINT-MIND study was a sub-study of the SPRINT study to examine how intensive blood pressure interventions affect the incidence of MCI and dementia [42].”
BackgroundInfluentialCugelman, B., Thelwall, M., & Dawes, P. (2011) · Journal of Medical Internet Research · doi:10.2196/jmir.1367 · Cited by 323 · cited 1×
“Adherence to digitally delivered programs is an important area of current research [91,92], with evidence supporting the role of content and intervention tailoring to specific populations and individuals to improve adherence [93,94].”
BackgroundDangour, A. D., Allen, E., Elbourne, D., Fasey, N., Fletcher, A. E., Hardy, P., Holder, G. E., Knight, R., Letley, L., Richards, M., et al. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.29121 · Cited by 296
The Value of Delaying Alzheimer’s Disease Onset
Zissimopoulos, J., Crimmins, E., & St.Clair, P. (2015) · Forum for Health Economics and Policy · doi:10.1515/fhep-2014-0013 · Cited by 267 · cited 1×
“Microsimulation models such as the Future Elderly Model have shown total societal savings of more than $100 billion from delaying disease onset by just one year in the US [97].”
Mobile health use in low- and high-income countries: an overview of the peer-reviewed literature
Bastawrous, A., & Armstrong, M. J. (2013) · Journal of the Royal Society of Medicine · doi:10.1177/0141076812472620 · Cited by 236
Sabia, S., Fayosse, A., Dumurgier, J., Schnitzler, A., Empana, J.-P., Ebmeier, K. P., Dugravot, A., Kivimäki, M., & Singh-Manoux, A. (2019) · BMJ · doi:10.1136/bmj.l4414 · Cited by 205
Cognitive and physical activity and dementia: A 44-year longitudinal population study of women
Najar, J., Östling, S., Gudmundsson, P., Sundh, V., Johansson, L., Kern, S., Guo, X., Hällström, T., & Skoog, I. (2019) · Neurology · doi:10.1212/wnl.0000000000007021 · Cited by 189
Dementia in low-income and middle-income countries: Different realities mandate tailored solutions
Ferri, C. P., & Jacob, K. S. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002271 · Cited by 154
SCHUBART, J. R., STUCKEY, H. L., GANESHAMOORTHY, A., & SCIAMANNA, C. N. (2011) · CIN: Computers, Informatics, Nursing · doi:10.1097/ncn.0b013e3182065eed · Cited by 135 · cited 1×
“Adherence to digitally delivered programs is an important area of current research [91,92], with evidence supporting the role of content and intervention tailoring to specific populations and individuals to improve adherence [93,94].”
Castro Sweet, C. M., Chiguluri, V., Gumpina, R., Abbott, P., Madero, E. N., Payne, M., Happe, L., Matanich, R., Renda, A., & Prewitt, T. (2018) · Journal of Aging and Health · doi:10.1177/0898264316688791 · Cited by 130
Self-citationColey, N., Ngandu, T., Lehtisalo, J., Soininen, H., Vellas, B., Richard, E., Kivipelto, M., Andrieu, S., & HATICE, F. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.03.005 · Cited by 118 · cited 2×
“A total of 1105 (88%) participants completed assessments for the full duration, with 1190 (94%) of participants included in final analysis, demonstrating effective adherence techniques [35].”
BackgroundRichard, E., Jongstra, S., Soininen, H., Brayne, C., Moll van Charante, E. P., Meiller, Y., van der Groep, B., Beishuizen, C. R. L., Mangialasche, F., Barbera, M., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010806 · Cited by 92
Cited by
Luo, J., Beam, C. R., & Gatz, M. (2023) · Prevention Science · doi:10.1007/s11121-022-01385-1 · Cited by 65
Anstey, K. J., Peters, R., Zheng, L., Barnes, D. E., Brayne, C., Brodaty, H., Chalmers, J., Clare, L., Dixon, R. A., Dodge, H., et al. (2020) · Journal of Alzheimer's Disease · doi:10.3233/jad-200674 · Cited by 40
“For example, leading multi-domain clinical trials such as FINGER, PreDIVA, and MYB, as well as other trials that are in development or in progress such as the US POINTER Trial, the MIND-China Trial, the SINGER Trial, CAN-THUMBS UP, HATICE, PRODEMOS, and SMARRT have been developed largely from evidence obtained in coho…”
BackgroundGray, M., Madero, E. N., Gills, J. L., Paulson, S., Jones, M. D., Campitelli, A., Myers, J., Bott, N. T., & Glenn, J. M. (2022) · JMIR Research Protocols · doi:10.2196/31841 · Cited by 15
Self-citation
Metadata
- Authors
- Bott, N. T., Hall, A., Madero, E. N., Glenn, J. M., Fuseya, N., Gills, J. L., & Gray, M.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2019-09-19
- Volume
- 11
- Issue
- 9
- Pages
- 2258
- ISSN
- 2072-6643 (ISSN-L)
- OpenAlex
- W2974826770
- Cited by
- 56
- References
- 37
- FWCI
- 3.69
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.